menu search

biocryst reports third quarter 2023 financial results and provides business update

– Q3 2023 ORLADEYO net revenue of $85.7 million (+29.8 percent y-o-y) — – Company expects to achieve no less than $320 million in full year 2023...

November 2, 2023, 11:00 am

biocryst to host r&d day on november 3

RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...

October 20, 2023, 11:00 am

biocryst (bcrx) surges 9.9%: is this an indication of further gains?

biocryst (BCRX) saw its shares surge in the last session with trading volume being higher than average....

September 19, 2023, 11:18 am

biocryst pharmaceuticals rallies on quebec reimbursement for orladeyo angioedema treatment

biocryst Pharmaceuticals (NASDAQ:BCRX) shares jumped in early Monday trading after it told investors th...

September 18, 2023, 10:53 am

biocryst pharmaceuticals, inc. (bcrx) q2 2023 earnings call transcript

biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM E...

August 3, 2023, 12:55 pm

biocryst to report second quarter 2023 financial results on august 3

RESEARCH TRIANGLE PARK, N.C., July 20, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...

July 20, 2023, 11:00 am

biocryst selects er-kim pharmaceuticals as commercial partner for orladeyo® (berotralstat) in turkey

RESEARCH TRIANGLE PARK, N.C., July 19, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasdaq...

July 19, 2023, 11:00 am

biocryst to present new orladeyo® (berotralstat) data at 2023 european academy of allergy and clinical immunology congress

RESEARCH TRIANGLE PARK, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- biocryst Pharmaceuticals Inc (Nasdaq: BC...

May 31, 2023, 7:02 am

Why biocryst pharmaceuticals stock is soaring today

biocryst Pharmaceuticals reported first-quarter earnings Wednesday morning. The financial report painte...

May 3, 2023, 1:44 pm

biocryst to report first quarter 2023 financial results on may 3

RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasda...

April 19, 2023, 11:00 am

biocryst to report first quarter 2023 financial results on may 3

RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- biocryst Pharmaceuticals, Inc. (Nasdaq...

April 19, 2023, 7:00 am

biocryst appoints dr. nancy hutson as chair of the board

RESEARCH TRIANGLE PARK, N.C., March 31, 2023 (GLOBE NEWSWIRE) — biocryst Pharmaceuticals, Inc. (Nasda...

March 31, 2023, 11:00 am

biocryst: good candidate for buyout, but not for anything else

biocryst Pharmaceuticals, Inc. has one blockbuster potential marketed drug, but not much of a pipeline....

March 8, 2023, 2:01 pm

Why shares of biocryst pharmaceuticals jumped today

A day after the stock plummeted, it bounced back....

February 22, 2023, 3:29 pm

biocryst is not currently uncovering the full value of orladeyo

biocryst's main value driver, ORLADEYO, is already profitable in its second year on the market and gene...

February 22, 2023, 9:00 am

biocryst pharmaceuticals, inc. (bcrx) q4 2022 earnings call transcript

biocryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q4 2022 Earnings Conference Call February 21, 2023 8:30 A...

February 21, 2023, 1:00 pm

Why biocryst pharmaceuticals stock is sinking today

Investors didn't like the drugmaker's Q4 update....

February 21, 2023, 11:55 am

biocryst pharmaceuticals (bcrx) reports q4 loss, tops revenue estimates

biocryst (BCRX) delivered earnings and revenue surprises of -100% and 6.11%, respectively, for the quar...

February 21, 2023, 9:47 am

Pharmaceutical stock sinks on sales forecast

biocryst Pharmaceuticals Inc (NASDAQ:BCRX) stock is sinking today, down 11.6% at $10.45 at last glance,...

January 9, 2023, 3:10 pm

biocryst pharmaceuticals: more aggressive growth for orladeyo

As a stellar drug for hereditary angioedema, biocryst Pharmaceuticals' Orladeyo is enjoying strong sale...

December 20, 2022, 4:47 pm


Search within

Pages Search Results: